Found: 201
Select item for more details and to access through your institution.
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 848, doi. 10.1007/s10637-018-0562-4
- By:
- Publication type:
- Article
Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 4, p. 255, doi. 10.1002/gcc.22431
- By:
- Publication type:
- Article
Therapeutic effects of metformin in breast cancer: involvement of the immune system?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1221, doi. 10.1007/s00262-011-1062-y
- By:
- Publication type:
- Article
Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 401, doi. 10.1007/s00262-010-0956-4
- By:
- Publication type:
- Article
Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 3, p. 479, doi. 10.1007/s00262-009-0801-9
- By:
- Publication type:
- Article
Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 887, doi. 10.1007/s00262-008-0605-3
- By:
- Publication type:
- Article
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predictors of resectability in breast-conserving therapy.
- Published in:
- Archives of Gynecology & Obstetrics, 2012, v. 286, n. 4, p. 1023, doi. 10.1007/s00404-012-2401-8
- By:
- Publication type:
- Article
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 3, p. 93, doi. 10.1159/000485566
- By:
- Publication type:
- Article
Targeted Therapy of HER2-Negative Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 3, p. 118, doi. 10.1159/000444204
- By:
- Publication type:
- Article
Heterogeneity of miR-10b expression in circulating tumor cells.
- Published in:
- Scientific Reports, 2015, p. 15980, doi. 10.1038/srep15980
- By:
- Publication type:
- Article
Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.
- Published in:
- International Journal of Cancer, 2003, v. 107, n. 3, p. 346, doi. 10.1002/ijc.11408
- By:
- Publication type:
- Article
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.
- Published in:
- International Journal of Cancer, 2002, v. 100, n. 3, p. 290, doi. 10.1002/ijc.10478
- By:
- Publication type:
- Article
Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0211337
- By:
- Publication type:
- Article
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection.
- Published in:
- Archives of Gynecology & Obstetrics, 2024, v. 309, n. 1, p. 235, doi. 10.1007/s00404-023-07080-y
- By:
- Publication type:
- Article
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 307, n. 4, p. 1105, doi. 10.1007/s00404-022-06726-7
- By:
- Publication type:
- Article
How previous treatment changes the metabolomic profile in patients with metastatic breast cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2022, v. 306, n. 6, p. 2115, doi. 10.1007/s00404-022-06558-5
- By:
- Publication type:
- Article
Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2022, v. 306, n. 3, p. 875, doi. 10.1007/s00404-022-06442-2
- By:
- Publication type:
- Article
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
„Breast-like cancer of unknown primary": Implikationen für die radiologische Diagnostik.
- Published in:
- Die Radiologie, 2023, v. 63, n. 5, p. 366, doi. 10.1007/s00117-023-01136-5
- By:
- Publication type:
- Article
Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01557
- By:
- Publication type:
- Article
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00987
- By:
- Publication type:
- Article
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
How the Consolidated Framework for Implementation Research Can Strengthen Findings and Improve Translation of Research Into Practice: A Case Study.
- Published in:
- Oncology Nursing Forum, 2017, v. 44, n. 5, p. E223, doi. 10.1188/17.ONF.E223-E231
- By:
- Publication type:
- Article
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9535, doi. 10.3390/ijms23179535
- By:
- Publication type:
- Article
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 2161, doi. 10.3390/ijms21062161
- By:
- Publication type:
- Article
Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 3, p. 900, doi. 10.3390/ijms19030900
- By:
- Publication type:
- Article
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11046-3
- By:
- Publication type:
- Article
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 14, p. 1018
- By:
- Publication type:
- Article
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 7, p. 1560, doi. 10.1038/s44321-024-00082-6
- By:
- Publication type:
- Article
Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 10, p. N.PAG, doi. 10.15252/emmm.201809003
- By:
- Publication type:
- Article
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 2, p. 957, doi. 10.1245/s10434-023-14551-8
- By:
- Publication type:
- Article
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 12, p. 3892, doi. 10.1245/s10434-019-07635-x
- By:
- Publication type:
- Article
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice.
- Published in:
- Current Oncology, 2021, v. 28, n. 4, p. 2741, doi. 10.3390/curroncol28040239
- By:
- Publication type:
- Article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1715, doi. 10.1038/s41416-021-01690-6
- By:
- Publication type:
- Article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial.
- Published in:
- British Journal of Cancer, 2021, v. 125, n. 7, p. 955, doi. 10.1038/s41416-021-01471-1
- By:
- Publication type:
- Article
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 2, p. 311, doi. 10.1007/s10549-022-06710-4
- By:
- Publication type:
- Article
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 137, doi. 10.1007/s10549-020-05746-8
- By:
- Publication type:
- Article
HER2-targeted therapy influences CTC status in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 182, n. 1, p. 127, doi. 10.1007/s10549-020-05687-2
- By:
- Publication type:
- Article
Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 2, p. 437, doi. 10.1007/s10549-019-05314-9
- By:
- Publication type:
- Article